Lv41
460 积分 2025-02-21 加入
Diagnostic value of lncRNAs LINC00152 and LARS2-AS1 and their regulatory roles in macrophage immune response in tuberculosis
44分钟前
已完结
Tuberculosis-infected macrophage exosomal miR-125b-5p induces osteoporosis by targeting IGF2 through the PI3K/AKT pathway
1小时前
已完结
Spinal tuberculosis
12小时前
已完结
Urinary Tract Infections in Patients with Chronic Renal Insufficiency
4个月前
已完结
Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes
7个月前
已完结
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
7个月前
已完结
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
7个月前
已完结
Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction
7个月前
已关闭
Tirzepatide: A novel cardiovascular protective agent in type 2 diabetes mellitus and obesity
7个月前
已完结
Tirzepatide: First Approval
7个月前
已完结
皖公网安备34019202002308
